Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (17304)
All Articles published online
|
Publishing Process of This Article
|
Jun 28, 2015 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Enomoto H, Bando Y, Nakamura H, Nishiguchi S, Koga M. Liver fibrosis markers of nonalcoholic steatohepatitis. World J Gastroenterol 2015; 21(24): 7427-7435 [PMID: 26139988 DOI: 10.3748/wjg.v21.i24.7427] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i24/7427.htm |
| Number | Citing Articles |
| 1 |
Josephine Z. Kasa-Vubu, Alexandra Waisanen, Julie Sturza, Vasantha Padmanabhan, Louise M. O’Brien. Weight-neutral approach and later sleep midpoint in adolescents with “emerging polycystic ovary syndrome phenotype” as vehicles for sustainable weight loss. F&S Reports 2024; doi: 10.1016/j.xfre.2024.09.001
|
| 2 |
Ahmed Ba‐Ssalamah, Nina Bastati, Andreas Wibmer, Romana Fragner, Jacqueline C. Hodge, Michael Trauner, Christian J. Herold, Mustafa R. Bashir, Bernard E. Van Beers. Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?. Journal of Magnetic Resonance Imaging 2017; 45(3): 646 doi: 10.1002/jmri.25518
|
| 3 |
Hsu-Feng Lu, Yu-Heng Lai, Hsiu-Chen Huang, I-Jung Lee, Lie-Chwen Lin, Hui-Kang Liu, Hsiao-Hsuan Tien, Cheng Huang. Ginseng-plus-Bai-Hu-Tang ameliorates diet-induced obesity, hepatic steatosis, and insulin resistance in mice. Journal of Ginseng Research 2020; 44(2): 238 doi: 10.1016/j.jgr.2018.10.005
|
| 4 |
Luis Rolando Guarneros-Nolasco, Giner Alor-Hernández, Guillermo Prieto-Avalos, José Luis Sánchez-Cervantes. Early Identification of Risk Factors in Non-Alcoholic Fatty Liver Disease (NAFLD) Using Machine Learning. Mathematics 2023; 11(13): 3026 doi: 10.3390/math11133026
|
| 5 |
Evrim Kahramanoğlu Aksoy, Zeynep Göktaş, Özgür Albuz, Muhammet Yener Akpınar, Doğan Öztürk, Hakan Buluş, Metin Uzman. Effects of sleeve gastrectomy on liver enzymes, non-alcoholic fatty liver disease-related fibrosis and steatosis scores in morbidly obese patients: first year follow-up. Journal of Laboratory Medicine 2019; 43(2): 115 doi: 10.1515/labmed-2018-0181
|
| 6 |
Katelynn S. Madill-Thomsen, Marwan Abouljoud, Chandra Bhati, Michał Ciszek, Magdalena Durlik, Sandy Feng, Bartosz Foroncewicz, Iman Francis, Michał Grąt, Krzysztof Jurczyk, Goran Klintmalm, Maciej Krasnodębski, Geoff McCaughan, Rosa Miquel, Aldo Montano-Loza, Dilip Moonka, Krzysztof Mucha, Marek Myślak, Leszek Pączek, Agnieszka Perkowska-Ptasińska, Grzegorz Piecha, Trevor Reichman, Alberto Sanchez-Fueyo, Olga Tronina, Marta Wawrzynowicz-Syczewska, Andrzej Więcek, Krzysztof Zieniewicz, Philip F. Halloran. The molecular phenotypes of injury, steatohepatitis, and fibrosis in liver transplant biopsies in the INTERLIVER study. American Journal of Transplantation 2022; 22(3): 909 doi: 10.1111/ajt.16890
|
| 7 |
Tong-Shuo Zhang, Hua-Lei Qin, Tong Wang, Hai-Tao Li, Hai Li, Shi-Hai Xia, Xiao-Hui Xiang. Bibliometric analysis of top 100 cited articles in nonalcoholic fatty liver disease research. World Journal of Hepatology 2016; 8(33): 1478-1488 doi: 10.4254/wjh.v8.i33.1478
|
| 8 |
Marta Iruarrizaga-Lejarreta, Fernando Bril, Mazen Noureddin, Pablo Ortiz, Shelly C. Lu, José M. Mato, Cristina Alonso. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. 2019; : 423 doi: 10.1007/978-3-030-11748-1_16
|
| 9 |
Saad Mazhar, Aima Azhar, Ariba Khan, Gulrukh Shakil, Sapna Kumari, Deepa Devi, Sayed Jawad. Efficacy and safety of resmetirom among patients with non-alcoholic steatohepatitis: a systematic review and meta-analysis. Annals of Medicine & Surgery 2024; 86(9): 5447 doi: 10.1097/MS9.0000000000002314
|
| 10 |
Pei-Xin Hu, Mei-Yan Sheng, Yan-Ping Liu, Chun-Qing Zhang. FOSL2 deficiency delays nonalcoholic steatohepatitis progression by regulating LY6D-mediated NLRP3 activation. Human Cell 2022; 35(6): 1752 doi: 10.1007/s13577-022-00760-y
|
| 11 |
Hiroki Nishikawa, Hirayuki Enomoto, Yoshinori Iwata, Kyohei Kishino, Yoshihiro Shimono, Kunihiro Hasegawa, Chikage Nakano, Ryo Takata, Kazunori Yoh, Takashi Nishimura, Nobuhiro Aizawa, Yoshiyuki Sakai, Naoto Ikeda, Tomoyuki Takashima, Akio Ishii, Hiroko Iijima, Hideji Nakamura, Shuhei Nishiguchi. Clinical significance of serum Wisteria floribunda agglutinin positive Mac‐2‐binding protein level in non‐alcoholic steatohepatitis. Hepatology Research 2016; 46(12): 1194 doi: 10.1111/hepr.12662
|
| 12 |
Jialu Liu, Xinhao Han, Lu Chen, Liudan Mai, Xiaoman Su, Yanlin Dong, Baolong Wang, Qiuju Zhang. The Association between Diet–Exercise Patterns and Cirrhosis: A Cross-Sectional Study from NHANES 2017-March 2020. Nutrients 2024; 16(11): 1617 doi: 10.3390/nu16111617
|
| 13 |
Yingwei Zhu, Hong Tang, Han Zhao, Jian Lu, Kai Lin, Jingbin Ni, Bo Zhao, Gaojue Wu, Chunxiao Tan. Vinpocetine represses the progression of nonalcoholic steatohepatitis in mice by mediating inflammasome components via NF-κB signaling. Gastroenterología y Hepatología (English Edition) 2024; 47(4): 366 doi: 10.1016/j.gastre.2023.07.006
|
| 14 |
Mahmoud Aryan, Ravi Jariwala, Basem Alkurdi, Shajan Peter, Mohamed Shoreibah. Prevalence of metabolic syndrome in cirrhotics with gastric antral vascular ectasia. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2022; 16(1): 102377 doi: 10.1016/j.dsx.2021.102377
|
| 15 |
Devon Chang, Emily Truong, Edward A. Mena, Fabiana Pacheco, Micaela Wong, Maha Guindi, Tsuyoshi T. Todo, Nabil Noureddin, Walid Ayoub, Ju Dong Yang, Irene K. Kim, Anita Kohli, Naim Alkhouri, Stephen Harrison, Mazen Noureddin. Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD‐related cirrhosis. Hepatology 2023; 77(2): 546 doi: 10.1002/hep.32655
|
| 16 |
Zu-Yin Li, Gang Wu, Chen Qiu, Zhi-Jie Zhou, Yu-Peng Wang, Guo-He Song, Chao Xiao, Xin Zhang, Gui-Long Deng, Rui-Tao Wang, Yu-Long Yang, Xiao-Liang Wang. Mechanism and therapeutic strategy of hepatic <i>TM6SF2</i>-deficient non-alcoholic fatty liver diseases <i>via in vivo</i> and <i>in vitro</i> experiments. World Journal of Gastroenterology 2022; 28(25): 2937-2954 doi: 10.3748/wjg.v28.i25.2937
|
| 17 |
Adi S. Yehezkel, Nathalie Abudi, Yuval Nevo, Hadar Benyamini, Sharona Elgavish, Marta Weinstock, Rinat Abramovitch. AN1284 attenuates steatosis, lipogenesis, and fibrosis in mice with pre-existing non-alcoholic steatohepatitis and directly affects aryl hydrocarbon receptor in a hepatic cell line. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1226808
|
| 18 |
Gao Sun, Charles V. Jackson, Karen Zimmerman, Li-Kun Zhang, Courtney M. Finnearty, George E. Sandusky, Guodong Zhang, Richard G. Peterson, Yi-Xin (Jim) Wang. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0958-4
|
| 19 |
Qi Liu, Yue Sun, Yue Zhu, Senqiu Qiao, Jingzeng Cai, Ziwei Zhang. Melatonin relieves liver fibrosis induced by Txnrd3 knockdown and nickel exposure via IRE1/NF-kB/NLRP3 and PERK/TGF-β1 axis activation. Life Sciences 2022; 301: 120622 doi: 10.1016/j.lfs.2022.120622
|
| 20 |
Huimin Dong, Lu Zhao, Hengchang Sun, Mei Shang, Gang Lv, Xinbing Yu, Bo Hu, Yan Huang. Coinfection of Clonorchis sinensis and hepatitis B virus: clinical liver indices and interaction in hepatic cell models. Parasites & Vectors 2022; 15(1) doi: 10.1186/s13071-022-05548-5
|
| 21 |
Yukimura Higashiura, Marenao Tanaka, Kazuma Mori, Takuma Mikami, Itaru Hosaka, Hirofumi Ohnishi, Nagisa Hanawa, Masato Furuhashi, Magnus Bäck. High fibrosis-4 index predicts the new onset of ischaemic heart disease during a 10-year period in a general population. European Heart Journal Open 2022; 2(3) doi: 10.1093/ehjopen/oeac030
|
| 22 |
Tianyi Li, Yuhao Feng, Yan Liu, Haina Wang. The role of organic anion transport peptides in cyclophosphamide-induced hepatotoxicity in high-fat diet mice. Life Sciences 2024; 359: 123239 doi: 10.1016/j.lfs.2024.123239
|
| 23 |
Jung Yeon Joo, In Hyuk Yoo, Hye Ran Yang. Serologic Biomarkers for Hepatic Fibrosis in Obese Children with Nonalcoholic Steatohepatitis. Pediatric Gastroenterology, Hepatology & Nutrition 2024; 27(4): 236 doi: 10.5223/pghn.2024.27.4.236
|
| 24 |
V A Akhmedov, O V Gaus. Involvement of the hepatobiliary system and pancreas in obesity. Terapevticheskii arkhiv 2017; 89(1): 128 doi: 10.17116/terarkh2017891128-133
|
| 25 |
Jung Yoon Pyo, Sung Soo Ahn, Lucy Eunju Lee, Ha Na Choe, Jason Jungsik Song, Yong‐Beom Park, Sang‐Won Lee. Efficacy of the fibrosis index for predicting end‐stage renal disease in patients with antineutrophil cytoplasmic antibody‐associated vasculitis. International Journal of Clinical Practice 2021; 75(4) doi: 10.1111/ijcp.13929
|
| 26 |
Narriane C. P. Holanda, Amanda R. L. Oliveira, Nara N. C. Carvalho, Bruno L. Souza. Endocrinology and Diabetes. 2022; : 443 doi: 10.1007/978-3-030-90684-9_42
|
| 27 |
Mandour Omer Mandour, Mohammed El-Hassan, Rawan M Elkomi, Jude A Oben. Non-alcoholic fatty liver disease: Is surgery the best current option and can novel endoscopy play a role in the future?. World Journal of Hepatology 2022; 14(9): 1704-1717 doi: 10.4254/wjh.v14.i9.1704
|
| 28 |
Tasur Kumar Seen, Muntazir Sayed, Muhammad Bilal, Jonathan Vincent Reyes, Priyanka Bhandari, Vennis Lourdusamy, Ahmed Al-khazraji, Umer Syed, Yasar Sattar, Raghav Bansal. Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis. World Journal of Gastroenterology 2021; 27(23): 3238-3248 doi: 10.3748/wjg.v27.i23.3238
|
| 29 |
Ellen Vercalsteren, Christine Vranckx, Liesbeth Frederix, Marleen Lox, H. Roger Lijnen, Ilse Scroyen, Bianca Hemmeryckx. Advanced-age C57BL/6JRj mice do not develop obesity upon western-type diet exposure. Adipocyte 2019; 8(1): 105 doi: 10.1080/21623945.2019.1590893
|
| 30 |
Fengxing Li, Kai Zou, Ning Chen. Exercise, Autophagy and Chronic Diseases. 2021; : 81 doi: 10.1007/978-981-16-4525-9_5
|
| 31 |
Nicolás Salva-Pastor, Norberto C. Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver disease. The Journal of Steroid Biochemistry and Molecular Biology 2019; 194: 105445 doi: 10.1016/j.jsbmb.2019.105445
|
| 32 |
Shu‐Chen Cheng, Chian‐Jiun Liou, Ya‐Xuan Wu, Kuo‐Wei Yeh, Li‐Chen Chen, Wen‐Chung Huang. Gypenoside XIII regulates lipid metabolism in HepG2 hepatocytes and ameliorates nonalcoholic steatohepatitis in mice. The Kaohsiung Journal of Medical Sciences 2024; 40(3): 280 doi: 10.1002/kjm2.12795
|
| 33 |
Rochelle W. Lai, Ryan Lu, Prakroothi S. Danthi, Juan I. Bravo, Alexandre Goumba, Nirmal Kumar Sampathkumar, Bérénice A. Benayoun. Multi-level remodeling of transcriptional landscapes in aging and longevity. BMB Reports 2019; 52(1): 86 doi: 10.5483/BMBRep.2019.52.1.296
|
| 34 |
Chao Zhang, Chuanbao Zhang. Analysis of current status of quantitative detection of biomarkers for liver fibrosis in Clinical labs in China. Journal of Clinical Laboratory Analysis 2022; 36(7) doi: 10.1002/jcla.24490
|
| 35 |
Ting Zhai, Wei Xu, Yayun Liu, Kun Qian, Yanling Xiong, Yong Chen, Tullia Maraldi. Honokiol Alleviates Methionine-Choline Deficient Diet-Induced Hepatic Steatosis and Oxidative Stress in C57BL/6 Mice by Regulating CFLAR-JNK Pathway. Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/2313641
|
| 36 |
Yingwei Zhu, Hong Tang, Han Zhao, Jian Lu, Kai Lin, Jingbin Ni, Bo Zhao, Gaojue Wu, Chunxiao Tan. Vinpocetine represses the progression of nonalcoholic steatohepatitis in mice by mediating inflammasome components via NF-κB signaling. Gastroenterología y Hepatología 2024; 47(4): 366 doi: 10.1016/j.gastrohep.2023.07.006
|
| 37 |
Yun Feng, Wenhua Li, Zhuoya Wang, Ruling Zhang, Yan Li, Lijuan Zang, Peiwen Wang, Zhenghong Li, Yuwei Dong. The p-STAT3/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitis. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03692-1
|
| 38 |
Hua-Chien Wu, Yin-Ru Hsieh, Weu Wang, Ching-Wen Chang, I-Wei Chang, Chi-Long Chen, Chun-Chao Chang, Chia-Hsuan Chang, Wei-Yu Kao, Shih-Yi Huang. Potential Hepatic Lipid Markers Associated with Nonalcoholic Steatohepatitis and Fibrosis in Morbid Obesity Patients. Journal of Clinical Medicine 2023; 12(11): 3730 doi: 10.3390/jcm12113730
|
| 39 |
Sang Oh Yun, Jong Man Kim, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh. Fibrosis-4 index, a predictor for prognosis of hepatocellular carcinoma patients after curative hepatectomy even in hepatitis B virus dominant populations. Annals of Surgical Treatment and Research 2023; 104(4): 195 doi: 10.4174/astr.2023.104.4.195
|
| 40 |
Anushri Parakh, Vinit Baliyan, Dushyant V. Sahani. Dual-Energy CT in Focal and Diffuse Liver Disease. Current Radiology Reports 2017; 5(8) doi: 10.1007/s40134-017-0226-8
|
| 41 |
You Yang, Xile Jiang, Stephen J. Pandol, Yuan-Ping Han, Xiaofeng Zheng. Green Plant Pigment, Chlorophyllin, Ameliorates Non-alcoholic Fatty Liver Diseases (NAFLDs) Through Modulating Gut Microbiome in Mice. Frontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.739174
|
| 42 |
Julie F.N. Potier, Andy E. Durham, Raakesh Modi, William Rosenberg, Sophie A. Dash. Investigation of Serum Markers of Hepatic Fibrosis in Equids. Journal of Equine Veterinary Science 2023; 131: 104937 doi: 10.1016/j.jevs.2023.104937
|
| 43 |
Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Tadanobu Nagaya, Michiharu Komatsu, Eiji Tanaka. Current status, problems, and perspectives of non-alcoholic fatty liver disease research. World Journal of Gastroenterology 2019; 25(2): 163-177 doi: 10.3748/wjg.v25.i2.163
|
| 44 |
Arianna Ferro, Gabriele Saccu, Simone Mattivi, Andrea Gaido, Maria Beatriz Herrera Sanchez, Shafiul Haque, Lorenzo Silengo, Fiorella Altruda, Marilena Durazzo, Sharmila Fagoonee. Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases. Biomolecules 2024; 14(3): 277 doi: 10.3390/biom14030277
|
| 45 |
Letícia F Ramos, Caio M Silva, Camila C Pansa, Karen C M Moraes. Non-alcoholic fatty liver disease: molecular and cellular interplays of the lipid metabolism in a steatotic liver. Expert Review of Gastroenterology & Hepatology 2021; 15(1): 25 doi: 10.1080/17474124.2020.1820321
|
| 46 |
Xiangzhou Shi, Jinghua Li, Binying Min, Ruijing Yang, Chunxiang He, Yilin Yang, Chen Ling. Application of ultrasound elastography for monitoring the effects of TβR1 shRNA therapy on hepatic fibrosis in a rat model. PLOS ONE 2021; 16(6): e0253150 doi: 10.1371/journal.pone.0253150
|
| 47 |
O. S. Popova, V. S. Ponamarev, A. V. Kostrova, L. A. Agafonova. Use of modern methods for diagnostics of diseases of the heptobiliary system. International Journal of Veterinary Medicine 2023; (1): 113 doi: 10.52419/issn2072-2419.2023.1.113
|
| 48 |
Luai Huleihel, Michelle E. Scarritt, Stephen F. Badylak. The Influence of Extracellular RNA on Cell Behavior in Health, Disease, and Regeneration. Current Pathobiology Reports 2017; 5(1): 13 doi: 10.1007/s40139-017-0121-2
|
| 49 |
Lina Jiang, Mei Yang, Xi Li, Yijin Wang, Guangde Zhou, Jingmin Zhao. CXC Motif Ligand 16 Promotes Nonalcoholic Fatty Liver Disease Progression via Hepatocyte–Stellate Cell Crosstalk. The Journal of Clinical Endocrinology & Metabolism 2018; 103(11): 3974 doi: 10.1210/jc.2018-00762
|
| 50 |
Saleh A. Alqahtani, Pegah Golabi, James M. Paik, Brian Lam, Amir H. Moazez, Hazem A. Elariny, Zachary Goodman, Zobair M. Younossi. Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease. Obesity Surgery 2021; 31(5): 2002 doi: 10.1007/s11695-020-04996-1
|
| 51 |
Daniel A. Montes-Galindo, Ana C. Espiritu-Mojarro, Valery Melnikov, Norma A. Moy-López, Alejandro D. Soriano-Hernandez, Hector R. Galvan-Salazar, Jorge Guzman-Muñiz, Jose Guzman-Esquivel, Margarita L. Martinez-Fierro, Iram P. Rodriguez-Sanchez, Brenda Paz-Michel, Sergio A. Zaizar-Fregoso, Carmen A. Sanchez-Ramirez, Mario Ramirez-Flores, Ivan Delgado-Enciso. Adenovirus 5 produces obesity and adverse metabolic, morphological, and functional changes in the long term in animals fed a balanced diet or a high-fat diet: a study on hamsters. Archives of Virology 2019; 164(3): 775 doi: 10.1007/s00705-018-04132-6
|
| 52 |
Yi-Jie Mao, Miao-Miao Ying, Gang Xu. Identification of hub genes and small molecule therapeutic drugs related to simple steatosis with secondary analysis of existing microarray data. All Life 2022; 15(1): 921 doi: 10.1080/26895293.2022.2114550
|
| 53 |
Madlen Matz-Soja, Christiane Rennert, Kristin Schönefeld, Susanne Aleithe, Jan Boettger, Wolfgang Schmidt-Heck, Thomas S Weiss, Amalya Hovhannisyan, Sebastian Zellmer, Nora Klöting, Angela Schulz, Jürgen Kratzsch, Reinhardt Guthke, Rolf Gebhardt. Hedgehog signaling is a potent regulator of liver lipid metabolism and reveals a GLI-code associated with steatosis. eLife 2016; 5 doi: 10.7554/eLife.13308
|
| 54 |
Rieko Nakatani, Takashi Murata, Takeshi Usui, Koki Moriyoshi, Toshiki Komeda, Yuichi Masuda, Maiko Kakita-Kobayashi, Tetsuya Tagami, Shinsaku Imashuku, Shigeo Kono, Kazunori Yamada, Akira Shimatsu. Importance of the Average Glucose Level and Estimated Glycated Hemoglobin in a Diabetic Patient with Hereditary Hemolytic Anemia and Liver Cirrhosis. Internal Medicine 2018; 57(4): 537 doi: 10.2169/internalmedicine.9135-17
|
| 55 |
Gi Cheol Park, Soo-Young Bang, Ji Min Kim, Sung-Chan Shin, Yong-il Cheon, Kwang Min Kim, Hanaro Park, Eui-Suk Sung, Minhyung Lee, Jin-Choon Lee, Byung-Joo Lee. Inhibiting Ferroptosis Prevents the Progression of Steatotic Liver Disease in Obese Mice. Antioxidants 2024; 13(11): 1336 doi: 10.3390/antiox13111336
|
| 56 |
Nidhi Sharma, Ramakrishna Sistla, Sai Balaji Andugulapati. Yohimbine ameliorates liver inflammation and fibrosis by regulating oxidative stress and Wnt/β-catenin pathway. Phytomedicine 2024; 123: 155182 doi: 10.1016/j.phymed.2023.155182
|
| 57 |
Katarzyna Zdanowicz, Monika Kowalczuk-Kryston, Witold Olanski, Irena Werpachowska, Wlodzimierz Mielech, Dariusz Marek Lebensztejn. Increase in Serum MMP-9 and TIMP-1 Concentrations during Alcohol Intoxication in Adolescents—A Preliminary Study. Biomolecules 2022; 12(5): 710 doi: 10.3390/biom12050710
|
| 58 |
Iria Cebreiros López, José Antonio Noguera Velasco. Valoración de la enfermedad por hígado graso no alcohólico desde el laboratorio clínico. Revista del Laboratorio Clínico 2018; 11(3): 163 doi: 10.1016/j.labcli.2017.10.004
|